ArticleJournal of clinical medicine2025

Testing the Efficacy of Eptinezumab 100 mg in the Early Prevention of Chronic Migraine over Weeks 1 to 4: Prospective Real-World Data from the GRASP Study Group.

Andreas A Argyriou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.